Peter Heerma

CIK 1789617 · CHIEF COMMERCIAL OFFICER · last filed 2026-05-06

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$7.32M

Companies

2

Total Filings

29

Lifetime Open-Market Net

-$2.04M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
TVTX CHIEF COMMERCIAL OFFICER 140,684 $52.04 $7.32M -$1.96M 26 2026-05-06
Travere Therapeutics, Inc. (RTRX) Delisted Chief Commercial Officer 44,517 -$83.7K 3 2020-10-05

Recent Filings · Page 2 of 3

29 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2025-01-23 TVTX Sell (S) −1,584 -$30.0K EDGAR
2024-09-09 TVTX Mixed +4,559 -$25.2K EDGAR
2024-02-02 TVTX Mixed +20,805 -$35.8K EDGAR
2024-01-25 TVTX Sell (S) −1,559 -$14.1K EDGAR
2023-10-04 TVTX Sell (S) −3,091 -$25.5K EDGAR
2023-02-02 TVTX Mixed +18,471 -$38.7K EDGAR
2023-01-26 TVTX Sell (S) −1,550 -$34.0K EDGAR
2022-10-06 TVTX Sell (S) −3,042 -$78.1K EDGAR
2022-02-02 TVTX Mixed +8,715 -$30.8K EDGAR
2022-01-26 TVTX Sell (S) −1,875 -$46.8K EDGAR
Showing 1120 of 29
Page 2 of 3
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.